In partnership with
JANUARY 6, 2026
composed by STEVE ULRICH
No publication covers NCAA Division III better. #whyD3
🏁 First Tuesday of the New Year. Let’s go.
🎶 Your Morning Pick-Me-Up. Espresso. Sabrina Carpenter
🗞 In Today’s Playbook. NCAA Defends House Settlement From Title IX, Opt-Out Appeal. Trinity, NYU Top Hoop Polls. Aurora Men Welcome In 2026 With Sweep of #2 Adrian. Springfield Tops Preseason Men’s Volleyball Poll. 40 Million Turn to ChatGPT For Health Care
💸 It’s a New Year’s Special. Subscribe to D3Playbook for just $4.99 per month. But hurry, this deal ends Friday at midnight.
A MESSAGE FROM MEDVi
Stop Waiting & Start Losing Weight Before for Just $179
Finally serious about weight loss? Join 500,000 weight loss patients & lose pounds of fat every week. MedVi provides highly effective GLP-1 treatments, personalized guidance, and everything you need to see real, consistent fat-loss results.
There are no membership fees, nothing confusing, and no insurance required. Just one simple, science-backed program that helps you get healthier each week.
Start today for only $179 and get free shipping.
Read all warnings before using GLP-ls. Side-effects may include a risk of thyroid c-cell tumors. Do not use GLP-1s if you or your family have a history of thyroid cancer. In certain situations, where clinically appropriate, a provider may prescribe compounded medication, which is prepared by a state-licensed sterile compounding pharmacy partner. Although compounded drugs are permitted to be prescribed under federal law, they are not FDA-approved and do not undergo FDA review for safety, effectiveness, or manufacturing quality.
Top Story
1. NCAA Defends House Settlement From Title IX, Opt-Out Appeal
“Objectors to U.S. District Judge Claudia Wilken’s approval of the settlement between the NCAA, its power conferences and current and former Division I athletes represented by the House, Carter and Hubbard antitrust litigations have raised unpersuasive and unsupported arguments, the NCAA and power conferences insist in a brief filed to the U.S. Court of Appeals for the Ninth Circuit last week.
Subscribe to Individual Package to read the rest.
Become a paying subscriber of Individual Package to get access to this post and other subscriber-only content.
UpgradeA subscription gets you:
- Five newsletters a week
- Access to interviews with decision-makers in DIII
- Access to the D3Podcast